Heart testmaker CardiOx has closed an $8 million series C round of investment that the company plans to use to begin U.S. and European commercialization, reports
WRAL Techwire.
The round was led by Michigan-based Lifeline Ventures and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO Larry Heaton says.
Read the full story
here.